| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP And Chief Medical Officer | EVP And Chief Medical Officer | EVP, Chief Medical Officer +2 more
2 companies
Eisner Mark is an EVP, Chief Medical Officer at FIBROGEN INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $2.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | VIR Vir Biotechnology, Inc. | EVP And Chief Medical Officer | Sell | 10,382 | $5.47 | $56,790.93 | -4.7% | +10.6% | - | |
| Jun 7, 2023 | KYNB Fibrogen Inc | EVP, Chief Medical Officer | Sell | 2,042 | $17.04 | $34,791.60 | -1.2% | -93.8% | -93.1% | |
| Jun 2, 2023 | KYNB Fibrogen Inc | EVP, Chief Medical Officer | Sell | 1,090 | $18.83 | $20,524.70 | -0.7% | -94.6% | -93.3% | |
| Apr 4, 2023 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 9,182 | $18.78 | $172,472.85 | -5.2% | -85.1% | -92.2% | |
| Mar 10, 2023 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 17,503 | $20.60 | $360,571.51 | -3.2% | -11.6% | -91.1% | |
| Mar 2, 2023 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 1,187 | $21.87 | $25,959.69 | -0.7% | -22.4% | -91.8% |